HDAC6 and primary cutaneous T-cell non-Hodgkin lymphoma: This causes excessive secretion of IL-15, which mediates the inflammation that is crucial in CTCL, suggesting this oncogenic loop can be controlled by modulation of HDAC1 and HDAC6 (Mishra et al., 2016).